Terlipressin acetate

Terlipressin acetate is a synthetic analogue of vasopressin used mainly as a vasoactive drug. It functions as a vasopressin receptor agonist causing vasoconstriction, which helps increase blood pressure and reduce bleeding in conditions including bleeding esophageal varices. It is also used to improve kidney function in adults with hepatorenal syndrome, especially where other drugs like norepinephrine have failed. It is grouped under the following drug class(es): Hormones, Peptides and Vasoconstrictors. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Terlipressin acetate anhydrous, Terlivaz and Heamopressin. Its PubChem CID is 72941948.

CAS No 914453-96-6
Molecular Formula C56H82N16O19S2
Molecular Weight 1347.5 g/mol
Synonyms acetic acid;(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide

Frequently Asked Questions